Published in J Virol on February 01, 1997
Virus maturation by budding. Microbiol Mol Biol Rev (1998) 3.78
Localization of mouse hepatitis virus nonstructural proteins and RNA synthesis indicates a role for late endosomes in viral replication. J Virol (1999) 2.49
Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein. J Virol (1999) 1.37
Two types of virus-related particles are found during transmissible gastroenteritis virus morphogenesis. J Virol (1998) 1.21
Amino acid substitutions within the leucine zipper domain of the murine coronavirus spike protein cause defects in oligomerization and the ability to induce cell-to-cell fusion. J Virol (1999) 1.19
The function of the spike protein of mouse hepatitis virus strain A59 can be studied on virus-like particles: cleavage is not required for infectivity. J Virol (1997) 1.14
The coronavirus spike protein induces endoplasmic reticulum stress and upregulation of intracellular chemokine mRNA concentrations. J Virol (2007) 0.93
Protein sorting by transport vesicles. Science (1996) 7.47
Folding and assembly of viral membrane proteins. Virology (1993) 4.63
Budding of rabies virus particles in the absence of the spike glycoprotein. Cell (1996) 4.46
Isolation and identification of virus-specific mRNAs in cells infected with mouse hepatitis virus (MHV-A59). Virology (1981) 4.01
Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant. J Virol (1989) 3.81
Envelope proteins of vesicular stomatitis virus: effect of temperature-sensitive mutations in complementation groups III and V. J Virol (1974) 3.73
Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J (1996) 3.33
Characterization of the budding compartment of mouse hepatitis virus: evidence that transport from the RER to the Golgi complex requires only one vesicular transport step. J Cell Biol (1994) 2.92
The endoplasmic reticulum as a protein-folding compartment. Trends Cell Biol (1992) 2.64
Replication of coronavirus MHV-A59 in sac- cells: determination of the first site of budding of progeny virions. Eur J Cell Biol (1984) 2.61
Tunicamycin resistant glycosylation of coronavirus glycoprotein: demonstration of a novel type of viral glycoprotein. Virology (1981) 2.34
Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin. J Virol (1981) 2.27
Repair and mutagenesis of the genome of a deletion mutant of the coronavirus mouse hepatitis virus by targeted RNA recombination. J Virol (1992) 2.20
The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virus. Virology (1996) 2.15
A domain at the 3' end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs. J Virol (1991) 2.14
The budding mechanism of spikeless vesicular stomatitis virus particles. EMBO J (1986) 1.81
Envelope glycoprotein interactions in coronavirus assembly. J Cell Biol (1995) 1.79
Lines of BPV-transformed murine cells that constitutively express influenza virus hemagglutinin. EMBO J (1985) 1.66
Assembly of coronavirus spike protein into trimers and its role in epitope expression. J Virol (1990) 1.60
Mutational analysis of the murine coronavirus spike protein: effect on cell-to-cell fusion. Virology (1995) 1.54
Construction of murine coronavirus mutants containing interspecies chimeric nucleocapsid proteins. J Virol (1995) 1.43
A fusion-defective mutant of the vesicular stomatitis virus glycoprotein. J Virol (1990) 1.37
Disulfide bonds in folding and transport of mouse hepatitis coronavirus glycoproteins. J Virol (1993) 1.21
Stably expressed FIPV peplomer protein induces cell fusion and elicits neutralizing antibodies in mice. Virology (1989) 1.19
Replication of synthetic defective interfering RNAs derived from coronavirus mouse hepatitis virus-A59. Virology (1996) 1.12
Map locations of mouse hepatitis virus temperature-sensitive mutants: confirmation of variable rates of recombination. J Virol (1994) 1.08
Temperature-sensitive mutants of mouse hepatitis virus strain A59: isolation, characterization and neuropathogenic properties. Virology (1983) 1.05
Analysis of second-site revertants of a murine coronavirus nucleocapsid protein deletion mutant and construction of nucleocapsid protein mutants by targeted RNA recombination. J Virol (1995) 1.03
Complementation of a vesicular stomatitis virus glycoprotein G mutant with wild-type protein expressed from either a bovine papilloma virus or a vaccinia virus vector system. Virology (1990) 0.93
Biosynthesis and function of the coronavirus spike protein. Adv Exp Med Biol (1990) 0.90
Events in the endoplasmic reticulum abrogate the temperature sensitivity of Sindbis virus mutant ts23. J Virol (1996) 0.89
A conditional-lethal murine coronavirus mutant that fails to incorporate the spike glycoprotein into assembled virions. Virus Res (1995) 0.88
Coronavirus mRNA synthesis involves fusion of non-contiguous sequences. EMBO J (1983) 3.13
Almost the entire 5' non-translated region of hepatitis C virus is required for cap-independent translation. FEBS Lett (1995) 2.72
Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses. Proc Natl Acad Sci U S A (1988) 2.24
Comparison of costs of percutaneous transluminal coronary angioplasty and coronary bypass surgery for patients with angina pectoris. Eur Heart J (1990) 1.74
Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years). Eur Heart J (2004) 1.66
The E3 protein of bovine coronavirus is a receptor-destroying enzyme with acetylesterase activity. J Virol (1988) 1.60
Direct visualization of receptor arrays in frozen-hydrated sections and plunge-frozen specimens of E. coli engineered to overproduce the chemotaxis receptor Tsr. J Microsc (2004) 1.56
Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum (1997) 1.46
25 years of aortic valve replacement using mechanical valves. Risk factors for early and late mortality. Eur Heart J (1997) 1.40
Human cartilage gp-39+,CD16+ monocytes in peripheral blood and synovium: correlation with joint destruction in rheumatoid arthritis. Arthritis Rheum (2000) 1.39
Persistent right sinus venosus valve. Br Heart J (1982) 1.31
Long-term follow-up (9 to 20 years) after surgical closure of atrial septal defect at a young age. Am J Cardiol (1993) 1.30
Specific sequelae after Fontan operation at mid- and long-term follow-up. Arrhythmia, liver dysfunction, and coagulation disorders. J Thorac Cardiovasc Surg (1993) 1.29
Management of fixed subaortic stenosis: a retrospective study of 57 cases. J Am Coll Cardiol (1992) 1.27
Recommendations of the Coronavirus Study Group for the nomenclature of the structural proteins, mRNAs, and genes of coronaviruses. Virology (1990) 1.21
Long-term follow-up after surgical closure of ventricular septal defect in infancy and childhood. J Am Coll Cardiol (1994) 1.20
Detailed analysis of aortic valve endocarditis: comparison of precordial, esophageal and epicardial two-dimensional echocardiography with surgical findings. J Clin Ultrasound (1986) 1.17
Amino acid sequence of a conserved neutralizing epitope of murine coronaviruses. J Virol (1989) 1.15
Transesophageal echocardiography in evaluation and management after a Fontan procedure. J Am Coll Cardiol (1991) 1.13
Replication of synthetic defective interfering RNAs derived from coronavirus mouse hepatitis virus-A59. Virology (1996) 1.12
Juxtaductal pulmonary artery coarctation. An underestimated cause of branch pulmonary artery stenosis in patients with pulmonary atresia or stenosis and a ventricular septal defect. J Thorac Cardiovasc Surg (1990) 1.11
Behavioural and emotional problems in children and adolescents with congenital heart disease. Psychol Med (1993) 1.10
Ventricular free wall rupture: sudden, subacute, slow, sealed and stabilized varieties. Eur Heart J (1984) 1.10
Enhanced morphological diagnosis in infective endocarditis by transoesophageal echocardiography. Br Heart J (1990) 1.08
Wild-type mouse p53 down-regulates transcription from different virus enhancer/promoters. Oncogene (1993) 1.06
Histology after stenting of human saphenous vein bypass grafts: observations from surgically excised grafts 3 to 320 days after stent implantation. J Am Coll Cardiol (1993) 1.05
The value of transoesophageal echocardiography for diagnosis of thoracic aorta pathology. Eur Heart J (1988) 1.03
Cardiac status and health-related quality of life in the long term after surgical repair of tetralogy of Fallot in infancy and childhood. J Thorac Cardiovasc Surg (1995) 1.02
Raised human cartilage glycoprotein-39 plasma levels in patients with rheumatoid arthritis and other inflammatory conditions. Ann Rheum Dis (2000) 1.02
Social support and the persistence of complaints in chronic fatigue syndrome. Psychother Psychosom (2004) 1.01
Cardiorespiratory and metabolic effects of profound hypothermia. Crit Care Med (1978) 1.01
Mode of action of protein synthesis initiation factor eIF-1 from rabbit reticulocytes. FEBS Lett (1980) 1.00
Long-term follow-up (10 to 17 years) after Mustard repair for transposition of the great arteries. J Thorac Cardiovasc Surg (1996) 0.99
Survival in 1041 patients with consecutive aorto-coronary bypass operations. Eur Heart J (1984) 0.96
Heterogeneity of endothelin/sarafotoxin receptors mediating contraction of the human isolated saphenous vein. Eur J Pharmacol (1993) 0.96
One stage repair of aortic arch anomalies and intracardiac defects. Eur J Cardiothorac Surg (1991) 0.96
Survival of metal-on-metal hip resurfacing arthroplasty: a systematic review of the literature. J Bone Joint Surg Br (2011) 0.95
Clinical outcome of single versus sequential grafts in coronary bypass operations at ten years' follow-up. J Thorac Cardiovasc Surg (1991) 0.95
5-Hydroxytryptamine-induced contractions of the human isolated saphenous vein: involvement of 5-HT2 and 5-HT1D-like receptors, and a comparison with grafted veins. Naunyn Schmiedebergs Arch Pharmacol (1992) 0.94
Low-dose aspirin inhibits platelet-induced contraction of the human isolated coronary artery. A role for additional 5-hydroxytryptamine receptor antagonism against coronary vasospasm? Circulation (1994) 0.93
Coronary artery disease after heart transplantation: timing of coronary arteriography. J Heart Lung Transplant (1993) 0.92
Melanoma inhibitory activity, a biomarker related to chondrocyte anabolism, is reversibly suppressed by proinflammatory cytokines in rheumatoid arthritis. Ann Rheum Dis (2008) 0.92
Transcription strategy of coronaviruses: fusion of non-contiguous sequences during mRNA synthesis. Adv Exp Med Biol (1984) 0.92
An unusual problem during surgical removal of a broken guidewire. Ann Thorac Surg (1991) 0.92
Autoantigenic HCgp39 epitopes are presented by the HLA-DM-dependent presentation pathway in human B cells. J Immunol (2001) 0.90
Criteria for early extubation after intracardiac surgery in adults. Anesth Analg (1977) 0.90
Intraoperative two-dimensional echocardiography in congenital heart disease. J Am Coll Cardiol (1987) 0.89
5-Hydroxytryptamine stimulates human isolated atrium but not ventricle. Eur J Pharmacol (1993) 0.89
Probability of a return to work after either coronary balloon dilatation or coronary bypass surgery. Eur Heart J (1989) 0.89
Does the pulmonary autograft in the aortic position in adults increase in diameter? An echocardiographic study. J Thorac Cardiovasc Surg (1997) 0.88
Localization of fluorescently labeled structures in frozen-hydrated samples using integrated light electron microscopy. J Struct Biol (2012) 0.88
Temporary tricuspid valve detachment in closure of congenital ventricular septal defect. Eur J Cardiothorac Surg (1994) 0.88
Characterization of coated vesicles that participate in endocytic recycling. Traffic (2001) 0.88
Subaortic obstruction: intraoperative echocardiography as an adjunct to operation. Ann Thorac Surg (1990) 0.88
5-HT receptors mediating contractions of the isolated human coronary artery. Eur J Pharmacol (1993) 0.88
The detection of cytotoxic T cells with high-affinity receptors for donor antigens in the transplanted heart as a prognostic factor for graft rejection. Transplantation (1993) 0.87
Incidence, risk, and outcome of reintervention after aortocoronary bypass surgery. Br Heart J (1987) 0.87
Survival at 5 to 10 years after aorto-coronary bypass operations in 1041 consecutive patients. Eur Heart J (1987) 0.87
Human tissue valves in aortic position: determinants of reoperation and valve regurgitation. Circulation (2001) 0.86
Xanthine oxidoreductase activity in perfused hearts of various species, including humans. Circ Res (1990) 0.86
Aortic root replacement with pulmonary autograft in children. J Thorac Cardiovasc Surg (1994) 0.85
Characterization of the positive and negative inotropic effects of acetylcholine in the human myocardium. Eur J Pharmacol (1995) 0.85
Psychosocial functioning of young adults after surgical correction for congenital heart disease in childhood: a follow-up study. J Psychosom Res (1994) 0.85
Abnormal diurnal variation of blood pressure, cardiac output, and vascular resistance in cardiac transplant recipients. Circulation (1994) 0.85
Stimulation of immune-competent cells in vitro by human cardiac valve-derived endothelial cells. Ann Thorac Surg (1995) 0.84
Anatomy of the proximal coronary arteries as a risk factor in primary repair of common arterial trunk. J Cardiovasc Surg (Torino) (1994) 0.84
The production and evaluation of dog allolymphocytotoxins for donor selection in transplantation experiments. Transplantation (1971) 0.84
Endogenous HLA-DR-restricted presentation of the cartilage antigens human cartilage gp-39 and melanoma inhibitory activity in the inflamed rheumatoid joint. Arthritis Rheum (2007) 0.83
Cytokine gene expression profiles in human endomyocardial biopsy (EMB) derived lymphocyte cultures and in EMB tissue. Transpl Int (1994) 0.83
Recombinant genomic RNA of coronavirus MHV-A59 after coreplication with a DI RNA containing the MHV-RI spike gene. Virology (1997) 0.83
Cracks in cryopreserved aortic allografts and rapid thawing. Ann Thorac Surg (1995) 0.83
Subcoronary implantation or aortic root replacement for human tissue valves: sufficient data to prefer either technique? Ann Thorac Surg (1995) 0.82
Intraoperative two-dimensional echocardiography in complicated infective endocarditis of the aortic valve. J Thorac Cardiovasc Surg (1987) 0.82
[11-year survival following aortocoronary bypass surgery]. Ned Tijdschr Geneeskd (1991) 0.82
Fracture of a balloon on a wire device during coronary angioplasty. Cathet Cardiovasc Diagn (1989) 0.82
Malondialdehyde and glutathione production in isolated perfused human and rat hearts. Circ Res (1993) 0.82
Polyclonal versus monoclonal rejection prophylaxis after heart transplantation: a randomised study. Transpl Int (1992) 0.82
Reoperation after aortocoronary bypass procedure. Results in 53 patients in a group of 1041 with consecutive first operations. Br Heart J (1983) 0.81
[Incidence and results of re-interventions following coronary vessel surgery]. Ned Tijdschr Geneeskd (1988) 0.81
Multiplane transoesophageal echocardiography and morphology of regurgitant mitral valves in surgical repair. Eur Heart J (1995) 0.81
Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane. Br J Pharmacol (1996) 0.80
Comparison of preoperative, operative and postoperative variables in asymptomatic or minimally symptomatic patients to severely symptomatic patients three years after coronary artery bypass grafting: analysis of 423 patients. Am J Cardiol (1985) 0.80
[Arg8]vasopressin-induced responses of the human isolated coronary artery: effects of non-peptide receptor antagonists. Eur J Pharmacol (1995) 0.80
Partial purification and characterization of individual histone messenger RNAs from HeLa cells. Biochem Biophys Res Commun (1976) 0.80
Unguarded tricuspid orifice with two-chambered right ventricle. Pediatr Cardiol (1986) 0.80
Absorption, distribution, metabolism and excretion of corifollitropin alfa, a recombinant hormone with a sustained follicle-stimulating activity. Pharmacology (2010) 0.80
Histocompatibility in orthotopic heart transplantation in dogs. Transplant Proc (1971) 0.80
Tandem coarctation of the thoracic aorta with hypoplasia of the abdominal aorta. Thorac Cardiovasc Surg (1985) 0.80
Chylothorax as a complication of harvesting the left internal thoracic artery in coronary artery bypass surgery. Eur J Cardiothorac Surg (1993) 0.79
Cloning and sequencing the nucleocapsid and E1 genes of coronavirus. Adv Exp Med Biol (1984) 0.79
[10 years of coronary surgery; results in 1041 patients operated on at the Thorax Center in Rotterdam]. Ned Tijdschr Geneeskd (1983) 0.79
Alloreactive lymphoid infiltrates in human heart transplants. Loss of class II-directed cytotoxicity more than 3 months after transplantation. Hum Immunol (1991) 0.79
Coronary angioplasty for early postinfarction unstable angina. Circulation (1986) 0.79
Cytotoxicity of 213Bi- and 225Ac-immunoconjugates. Nucl Med Commun (1995) 0.78
Postoperative regression of left ventricular dimensions in aortic insufficiency: a long-term echocardiographic study. J Am Coll Cardiol (1985) 0.78
Aorto-coronary bypass surgery in 62 patients with severe left ventricular dysfunction--a follow-up study. Thorac Cardiovasc Surg (1985) 0.78
Sequential versus conventional coronary artery bypass graft surgery in matched patient groups. Thorac Cardiovasc Surg (1981) 0.78
Selection of self-reactive peptides within human aggrecan by use of a HLA-DRB1*0401 peptide binding motif. J Autoimmun (1997) 0.78
Genetic fusion of an alpha-subunit gene to the follicle-stimulating hormone and chorionic gonadotropin-beta subunit genes: production of a bifunctional protein. Mol Endocrinol (1999) 0.78